The Metabolic Syndrome—Early Action to Decrease Risks for Cardiovascular Disease

Alberti K.G. , & Zimmet P.Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15(7). 539–553.

American Diabetes Association. (2004). Diagnosis and classification of diabetes mellitus. Diabetes Care American Diabetes Association: Clinical Practice Recommendations. 27(Suppl. 1), S5–S10.

Anonymous. (1998). Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—The Evidence Report. National Institutes of Health. Obesity Research, 6(Suppl. 2). 51S–209S.

Chen J. , Muntner P. , Hamm L.L. , Jones D.W. , Batuman V. , Fonseca V. , Whelton P.K. , & He J. (2004). The metabolic syndrome and chronic kidney disease in U.S. adults. Annals of Internal Medicine, 140(3), 167–174.

Chobanian A.V. , Bakris G.L. , Black H.R. , Cushman W.C. , Green L.A. , Izzo J.L. Jr. , Jones D.W. , Materson B.J. , Oparil S. , Wright J.T. Jr. , Roccella E.J. , Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, and National High Blood Pressure Education Program Coordinating Committee. (2003). Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42(6), 1206–1252.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Journal of the American Medical Association, 285(19), 2486–2497.

Ferrannini E. , Haffner S.M. , Mitchell B.D. , & Stern M.P. (1991). Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabelologia, 34(6). 416–422.

Ford E.S. , & Giles W.H. (2003). A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care, 26(3). 575–581.

Ford E.S. , Giles W.H. , & Dietz W.H. (2002). Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. Journal of the American Medical Association. 287(3), 356–359.

Hanley A.J. , Wagenknecht L.E. , D'Agostino R.B. Jr. , Zinman B. , & Haffner S.M. (2003). Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes, 52(11), 2740–2747.

Isomaa B. , Almgren P. , Tuomi T. , Forsen B. , Lahti K. , Nissen M. , Taskinen M.R. , & Groop L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683–689.

Iwane M. , Arita M. , Tomimoto S. , Satani O. , Matsumoto M. , Miyashita K. , & Nishio I. (2000). Walking 10,000 steps/day or more reduces blood pressure and sympathetic nerve activity in mild essential hypertension. Hypertension Research - Clinical and Experimental, 23(6), 573–580.

Lakka H.M. , Laaksonen D.E. , Lakka T.A. , Niskanen L.K. , Kumpusalo E. , Tuomilehto J. , & Salonen J.T. (2002). The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. Journal of the American Medical Association, 288(21), 2709–2716.

Laws A. , & Reaven G.M. (1992). Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. Journal of Internal Medicine, 231(1), 25–30.

McLaughlin T. , Abbasi F. , Cheal K. , Chu J. , Lamendola C. , & Reaven G. (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine, 139(10), 802–809.

Meigs J.B. , Wilson P.W. , Nathan D.M. , D'Agostino R.B. Sr. , Williams K. , & Haffner S.M. (2003). Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring studies. Diabetes, 52(8), 2160–2167.

Reaven G.M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37(12), 1595–1607.

Reaven G.M. (1995). Pathophysiology of insulin resistance in human disease. Physiological Reviews, 75(3), 473–486.

Samaha F.F. , Iqbal N. , Seshadri P. , Chicano K.L. , Daily D.A. , McGrory J. , Williams T. , Williams M. , Gracely E.J. , & Stern L. (2003). A low-carbohydrate as compared with a low-fat diet in severe obesity. New England Journal of Medicine, 348(21), 2074–2081.

Swartz A.M. , Strath S.J. , Bassett D.R. , Moore J.B. , Redwine B.A. , Groer M. , & Thompson D.L. (2003). Increasing daily walking improves glucose tolerance in overweight women. Preventive Medicine, 37(4), 356–362.

Wolever T.M. , & Mehling C. (2003). Long-term effect of varying the source or amount of dietary carbohydrate on postprandial plasma glucose, insulin, triacylglycerol, and free fatty acid concentrations in subjects with impaired glucose tolerance. American Journal of Clinical Nutrition, 77(3), 612–621.